Role of systemic therapy in advanced non-small-cell lung cancer
- 31 December 1990
- journal article
- review article
- Published by Elsevier in The American Journal of Medicine
- Vol. 89 (6) , 777-786
- https://doi.org/10.1016/0002-9343(90)90221-x
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- A randomised trial of cisplatin and vindesine versus supportive care only in advanced non-small cell lung cancerBritish Journal of Cancer, 1990
- Phase II Trial of Trimetrexate in Patients with Stage III and IV Non-Small-Cell Lung CancerAmerican Journal of Clinical Oncology, 1989
- Long-term observations of the patterns of failure in patients with unresectable non-oat cell carcinoma of the lung treated with definitive radiotherapy report by the radiation therapy oncology groupCancer, 1987
- A randomized trial of the four most active regimens for metastatic non-small-cell lung cancer.Journal of Clinical Oncology, 1986
- Camp chemotherapy for metastatic non-oat cell bronchogenic carcinoma. A 7-year experience (1975–1981) with 160 patientsCancer, 1985
- Unresectable Non-Small Cell Lung Cancer Chemotherapy with High-Dose Cisplatin and EtoposideOncology, 1985
- New agents in non-small cell lung cancerCancer Treatment Reviews, 1984
- Combination chemotherapy with cisplatin and etoposide in bronchogenic squamous cell carcinoma and adenocarcinoma. A study by the EORTC lung cancer working party (Belgium)Cancer, 1982
- Impact of irradiation technique and tumor extent in tumor control and survival of patients with unresectable non-oat cell carcinoma of the lung. Report by the radiation therapy oncology groupCancer, 1982
- Benefits of polychemotherapy in advanced non-small-cell bronchogenic carcinomaCancer, 1982